Who is sponsoring NCT03178240?

NCT03178240 is sponsored by University of Giessen.

What drugs are being tested in NCT03178240?

Interventions in NCT03178240: photoaging mirroring intervention.

What condition does NCT03178240 study?

NCT03178240 studies Skin Cancer.

Is NCT03178240 still recruiting?

NCT03178240 is currently status unknown. Last updated 6 June 2017.

Last reviewed 2017-06-06 · How we verify

NCT03178240

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sunface Mirroring RCT in Brazil

Status unknown NA Last updated 6 June 2017

What this trial tests

NA trial testing photoaging mirroring intervention in Skin Cancer in 1,000 participants. Status unknown.

Timeline

1 February 2018

Primary endpoint
1 October 2018

1 December 2018

Quick facts

Lead sponsor	University of Giessen
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	1,000
Start date	1 February 2018
Primary completion	1 October 2018
Estimated completion	1 December 2018

Drugs / interventions tested

photoaging mirroring intervention

Conditions studied

Skin Cancer — all drugs for Skin Cancer →

Sponsor

University of Giessen

Who can join

Adults 10 to 20, any sex, with Skin Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized trial looking at the effects of a behavioral photoaging software intervention on sunscreen use in the city of Itauna, Brazil.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Effect of a Face-Aging Mobile App-Based Intervention on Skin Cancer Protection Behavior in Secondary Schools in Brazil: A Cluster-Randomized Clinical Trial.
Brinker TJ, Faria BL, de Faria OM, Klode J, et al · · 2020 · cited 24× · PMID 32374352 · DOI 10.1001/jamadermatol.2020.0511
A skin cancer prevention photoageing intervention for secondary schools in Brazil delivered by medical students: protocol for a randomised controlled trial.
Brinker TJ, Faria BL, Gatzka M, de Faria OM, et al · · 2018 · cited 14× · PMID 29511007 · DOI 10.1136/bmjopen-2017-018299

Verify or expand the search:

Other recruiting trials for Skin Cancer

Currently open trials in the same condition.

NCT07288073 — TIL Therapy in cSCC and MCC · Phase 2 · recruiting
NCT06926075 — Early Phase Study of KESONOTIDE™in Participants With Solid Tumours · Phase 1, PHASE2 · recruiting
NCT06932172 — Artificial Intelligent Decision Support for Skin Cancer Diagnostics in Primary Care · NA · recruiting
NCT07510061 — Title: ICARUS - Psycho-physiological Profiling of Low and High Heat-resilient Individuals · NA · recruiting
NCT07200544 — Meloxicam in Mohs Micrographic Surgery · Phase 4 · recruiting

Other University of Giessen trials

Trials by the same sponsor.

NCT07505511 — Visualization of the Effects of Guideline-directed Medical Therapy (GDMT) on Improving Adherence and Quality of Life in · EARLY_PHASE1 · not yet recruiting
NCT07488468 — Quality Improvement Project to Reduce Preoperative Fasting Times Before Elective Procedures · recruiting
NCT06966739 — Multispectral Optoacustic Imaging in Patients With Myositis · completed
NCT06381427 — Perioperative Interdisciplinary, Intersectoral Process Optimization in Heart Failure · NA · recruiting
NCT06291714 — Non-invasive Measurement of the Hypotension Prediction Index for the Reduction of Intraoperative Hypotension · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03178240 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Giessen
Last refreshed: 6 June 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03178240.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing